Treatment of depression in the elderly: A review of the recent literature on the efficacy of single- versus dual-action antidepressants

Clinical Therapeutics

Volumn 31, Issue 5, 2009, Pages 945-961

  Mukai, Yuki ^a   Tampi, Rajesh R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aged; antidepressant therapy; depression; efficacy; review

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANXIETY; ASTHENIA; CLINICAL TRIAL; COMMON COLD; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DECREASED APPETITE; DELIRIUM; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; DRY EYE; DYSPEPSIA; EJACULATION DISORDER; FATIGUE; FLATULENCE; GASTROINTESTINAL DISEASE; GERIATRIC DEPRESSION SCALE; GERONTOPSYCHIATRY; HAMILTON SCALE; HEADACHE; HEART ARRHYTHMIA; HERPES ZOSTER; HUMAN; HUNGER; INFLUENZA; INSOMNIA; MEDICAL LITERATURE; MEDLINE; MICTURITION DISORDER; MINI MENTAL STATE EXAMINATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; PATIENT COMPLIANCE; PSYCHOSIS; PSYCINFO; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; REMISSION; RESTLESSNESS; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; STOMACH DISEASE; STOMACH PAIN; SWEATING; SYSTEMATIC REVIEW; TACHYCARDIA; TASTE DISORDER; TREATMENT OUTCOME; TREMOR; URINARY TRACT INFECTION; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

AGED; AGING; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 66949112551     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.05.016     Document Type: Review

References (41)

1. NIH Consensus Conference. Diagnosis and treatment of depression in late life. JAMA 268 (1992) 1018-1024
2. Rothschild A.J. The diagnosis and treatment of late-life depression. J Clin Psychiatry 57 Suppl 5 (1996) 5-11
3. Unützer J., Patrick D.L., Simon G., et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: A 4-year prospective study. JAMA 277 (1997) 1618-1623
4. Steffens D.C., Skoog I., Norton M.C., et al. Prevalence of depression and its treatment in an elderly population: The Cache County study. Arch Gen Psychiatry 57 (2000) 601-607
5. Newhouse P.A. Use of serotonin selective reuptake inhibitors in geriatric depression. J Clin Psychiatry 57 Suppl 5 (1996) 12-22
6. Alexopoulos G.S., Katz I.R., Reynolds III C.F., et al., the Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients. The Expert Consensus Guideline Series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med (2001) 1-86 (Spec No Pharmacotherapy)
7. Feighner J.P. Cardiovascular safety in depressed patients: Focus on venla-faxine. J Clin Psychiatry 56 (1995) 574-579
8. Ereshefsky L., and Dugan D. Review of the pharmacokinetics, pharmaco-genetics, and drug interaction potential of antidepressants: Focus on venlafaxine. Depress Anxiety 12 Suppl 1 (2000) 30-44
9. Thase M.E., Tran P.V., Wiltse C., et al. Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. J Clin Psychopharmacol 25 (2005) 132-140
10. Thase M.E., Entsuah A.R., and Rudolph R.L. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178 (2001) 234-241
11. Papakostas G.I., Thase M.E., Fava M., et al. Are antidepressant drugs that combine serotonergic and norad-renergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A metaanalysis of studies of newer agents. Biol Psychiatry 62 (2007) 1217-1227
12. Baumann P. Care of depression in the elderly: Comparative pharmacokinetics of SSRIs. Int Clin Psychopharmacol 13 Suppl 5 (1998) S35-S43
13. Krishnan K.R., Hays J.C., and Blazer D.G. MRI-defined vascular depression. Am J Psychiatry 154 (1997) 497-501
14. Taylor W.D., and Doraiswamy P.M. A systematic review of antidepressant placebo-controlled trials for geriatric depression: Limitations of current data and directions for the future. Neuropsychopharmacology 29 (2004) 2285-2299
15. Nelson J.C., Delucchi K., and Schneider L.S. Efficacy of second generation antidepressants in late-life depression: A meta-analysis of the evidence. Am J Geriatr Psychiatry 16 (2008) 558-567
16. Mottram P., Wilson K., and Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev. (2006) CD003491
17. Bose A., Li D., and Gandhi C. Escitalopram in the acute treatment of depressed patients aged 60 years or older. Am J Geriatr Psychiatry 16 (2008) 14-20
18. Gorwood P., Weiller E., Lemming O., and Katona C. Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 15 (2007) 581-593
19. Kasper S., de Swart H., and Friis Andersen H. Escitalopram in the treatment of depressed elderly patients. Am J Geriatr Psychiatry 13 (2005) 884-891
20. Roose S.P., Sackeim H.A., Krishnan K.R., et al., the Old-Old Depression Study Group. Antidepressant pharmacotherapy in the treatment of depression in the very old: A randomized, placebo-controlled trial. Am J Psychiatry 161 (2004) 2050-2059
21. Rapaport M.H., Schneider L.S., Dunner D.L., et al. Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry 64 (2003) 1065-1074
22. Dombrovski A.Y., Lenze E.J., Dew M.A., et al. Maintenance treatment for old-age depression preserves health-related quality of life: A randomized, controlled trial of paroxetine and interpersonal psychotherapy. J Am Geriatr Soc. 55 (2007) 1325-1332
23. Rossini D., Serretti A., Franchini L., et al. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: A doubleblind, randomized trial. J Clin Psychopharmacol 25 (2005) 471-475
24. Schneider L.S., Nelson J.C., Clary C.M., et al., the Sertraline Elderly Depression Study Group. An 8-week multicenter, parallel-group, doubleblind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 160 (2003) 1277-1285
25. Wilson K.C., Mottram P.G., Ashworth L., and Abou-Saleh M.T. Older community residents with depression: Long-term treatment with sertra-line. Randomised, double-blind, placebo-controlled study. Br J Psychiatry 182 (2003) 492-497
26. Sheikh J.I., Cassidy E.L., Doraiswamy P.M., et al. Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness [published correction appears in J Am Geriatr Soc. 2004;52:1228]. J Am Geriatr Soc. 52 (2004) 86-92
27. Rosenberg C., Lauritzen L., Brix J., et al. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: A Danish multicentre trial in general practice. Psychopharmacol Bull 40 (2007) 63-73
28. Wehmeier P.M., Kluge M., Maras A., et al. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. Pharmacopsychiatry 38 (2005) 13-16
29. Allard P., Gram L., Timdahl K., et al. Efficacy and tolerability of venla-faxine in geriatric outpatients with major depression: A double-blind, randomised 6-month comparative trial with citalopram. Int J Geriatr Psychiatry 19 (2004) 1123-1130
30. de Vasconcelos Cunha U.G., Lopes Rocha F., Avila de Melo R., et al. A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia. Dement Geriatr Cogn Disord 24 (2007) 36-41
31. Oslin D.W., Ten Have T.R., Streim J.E., et al. Probing the safety of medications in the frail elderly: Evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry 64 (2003) 875-882
32. Schatzberg A., and Roose S. A doubleblind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. Am J Geriatr Psychiatry 14 (2006) 361-370
33. Gastó C., Navarro V., Marcos T., et al. Single-blind comparison of venlafaxine and nortriptyline in elderly major depression. J Clin Pyschopharmacol 23 (2003) 21-26
34. Raskin J., Wiltse C.G., Dinkel J.J., et al. Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder. J Clin Pyschopharmacol 28 (2008) 32-38
35. Entsuah R., Derivan A., and Kikta D. Early onset of antidepressant action of venlafaxine: Pattern analysis in intent-to-treat patients. Clin Ther 20 (1998) 517-526
36. Bymaster F.P., Dreshfield-Ahmad L.J., Threlkeld P.G., et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 25 (2001) 871-880
37. Harvey A.T., Rudolph R.L., and Preskorn S.H. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry 57 (2000) 503-509
38. Fountoulakis K.N., O'Hara R., Iacovides A., et al. Unipolar late-onset depression: A comprehensive review. Ann Gen Hosp Psychiatry 2 (2003) 11
39. Dunner D.L. Treatment considerations for depression in the elderly. CNS Spectr 8 Suppl 3 (2003) 14-19
40. Bruce M.L., Ten Have T.R., Reynolds III C.F., et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: A randomized controlled trial. JAMA 291 (2004) 1081-1091
41. Alexopoulos G.S., Reynolds III C.F., et al. Pharmacotherapy of depression in older patients: A summary of the expert consensus guidelines. J Psychiatr Pract. 7 (2001) 361-376